Your browser doesn't support javascript.
loading
Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics.
Leder, Benjamin Z; Tsai, Joy N; Burnett-Bowie, Sherri-Anne; Bouxsein, Mary L; Neer, Robert M.
Affiliation
  • Leder BZ; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States. Electronic address: bzleder@partners.org.
  • Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
  • Burnett-Bowie SA; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
  • Bouxsein ML; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States; Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Neer RM; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Boston, MA, United States.
Bone ; 89: 73-74, 2016 08.
Article in En | MEDLINE | ID: mdl-27157641
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teriparatide / Bone Density Conservation Agents Limits: Humans Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2016 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teriparatide / Bone Density Conservation Agents Limits: Humans Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2016 Document type: Article Country of publication: Estados Unidos